NLM Digital Collections

Search

Start Over Formats Text ✖Remove constraint Formats: Text Collections Health Policy and Services Research ✖Remove constraint Collections: Health Policy and Services Research Subjects Humans ✖Remove constraint Subjects: Humans Subjects United States ✖Remove constraint Subjects: United States Subjects United States ✖Remove constraint Subjects: United States Languages English ✖Remove constraint Languages: English Genre Technical Report ✖Remove constraint Genre: Technical Report Copyright Copyright may apply ✖Remove constraint Copyright: Copyright may apply

1851. Targeted immune modulators for rheumatoid arthritis: effectiveness & value : evidence report

Publication:
Boston, MA : Institute for Clinical and Economic Review, March 10, 2017
Subject(s):
Arthritis, Rheumatoid -- drug therapy
Comparative Effectiveness Research
Immunologic Factors -- therapeutic use
Abatacept -- therapeutic use
Adalimumab -- therapeutic use
Certolizumab Pegol -- therapeutic use
Cost-Benefit Analysis
Etanercept -- therapeutic use
Immunologic Factors -- adverse effects
Immunologic Factors -- economics
Immunotherapy
Infliximab -- therapeutic use
Interleukin-6 -- antagonists & inhibitors
Protein Kinase Inhibitors -- therapeutic use
Randomized Controlled Trials as Topic
Rituximab -- therapeutic use
Treatment Outcome
Tumor Necrosis Factor-alpha -- antagonists & inhibitors
Value-Based Purchasing
Humans
United States

1852. Targeted immune modulators for rheumatoid arthritis: effectiveness and value : evidence report

Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, April 7, 2017
Subject(s):
Arthritis, Rheumatoid -- drug therapy
Arthritis, Rheumatoid -- immunology
Immunologic Factors -- therapeutic use
Abatacept -- therapeutic use
Adalimumab -- therapeutic use
Antirheumatic Agents -- adverse effects
Antirheumatic Agents -- therapeutic use
Certolizumab Pegol -- therapeutic use
Cost-Benefit Analysis
Drug Therapy, Combination
Etanercept -- therapeutic use
Immunologic Factors -- adverse effects
Infliximab -- therapeutic use
Interleukin-6 -- antagonists & inhibitors
Janus Kinase Inhibitors -- therapeutic use
Randomized Controlled Trials as Topic
Rituximab -- therapeutic use
Tumor Necrosis Factors -- antagonists & inhibitors
Humans
United States

1853. Targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: effectiveness and value : condition update : final evidence report

Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, August 3, 2018
Subject(s):
Immunologic Factors -- therapeutic use
Immunomodulation
Psoriasis -- drug therapy
Certolizumab Pegol -- therapeutic use
Clinical Trials as Topic
Cost-Benefit Analysis
Immunologic Factors -- adverse effects
Immunologic Factors -- economics
Quality of Life
Treatment Outcome
Humans
United States

1854. Targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: effectiveness and value : final evidence report

Publication:
Boston, MA : Institute for Clinical and Economic Review, December 2 2016
Subject(s):
Comparative Effectiveness Research
Immunologic Factors -- therapeutic use
Psoriasis -- drug therapy
Adalimumab -- therapeutic use
Benchmarking
Etanercept -- therapeutic use
Immunologic Factors -- adverse effects
Immunologic Factors -- economics
Interleukin-12 -- antagonists & inhibitors
Interleukin-17
Interleukin-23 -- antagonists & inhibitors
Phosphodiesterase 4 Inhibitors
Phototherapy
Psoriasis -- immunology
Psoriasis -- therapy
Randomized Controlled Trials as Topic
Severity of Illness Index
Tumor Necrosis Factor-alpha -- antagonists & inhibitors
Ustekinumab -- therapeutic use
Value-Based Purchasing
Humans
United States

1855. Teaching health centers: a promising approach for building primary care workforce for the 21st Century

Author(s):
Ku, Leighton, author
Mullan, Fitzhugh, author
Serrano, Cristine, author
Barber, Zoe, author
Shin, Peter, author
Publication:
[Washington, D.C.] : Milken Institute School of Public Health, George Washington University, March 10, 2015
Subject(s):
Community Health Centers -- statistics & numerical data
Community Health Services -- statistics & numerical data
Hospitals, Teaching
Internship and Residency -- statistics & numerical data
Primary Health Care
Primary Health Care -- statistics & numerical data
Education, Medical, Graduate
Health Workforce
Medically Underserved Area
Humans
United States

1856. Teen pregnancy: a winnable battle within reach

Author(s):
Dreisbach, Nicole, author
Publication:
[Washington, D.C.] : Grantmakers in Health, [2013]
Subject(s):
Adolescent Health Services
Pregnancy in Adolescence -- prevention & control
Adolescent
Birth Rate -- ethnology
Birth Rate -- trends
Contraception
Family Planning Services
Federal Government
Financing, Government
Financing, Organized
Forecasting
Pregnancy
Pregnancy in Adolescence -- ethnology
State Government
Female
Humans
Male
United States
Centers for Disease Control and Prevention (U.S.)

1859. Telemedicine in California: progress, challenges, and opportunities

Publication:
Oakland, Calif. : California HealthCare Foundation, c2008
Subject(s):
Diffusion of Innovation
Health Services Accessibility
Telemedicine -- economics
Telemedicine -- legislation & jurisprudence
Telemedicine -- trends
Blue Cross Blue Shield Insurance Plans
Forecasting
History, 20th Century
Medically Underserved Area
Mental Health Services
Ophthalmology
Patient Participation
Prisons
State Health Plans
Student Health Services
Telemedicine -- history
Telemedicine -- instrumentation
Humans
United States